← Evidence map

ArticleMolecular cancer2026

DCLK1 drives malignant progression and chemoresistance of bladder cancer by deubiquitinating HDAC6.

Ashuai Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41618382